While Johnson & Johnson isn't the first to secure FDA approval for an FcRn-blocking antibody in myasthenia gravis, the New ...

The Board of Directors of Financière de Tubizeappoints Bruno Holthof as new Chair As Gaëtan Hannecart did not seek renewal of his director's mandate at the general shareholders meeting held on April ...

Industry Veteran Brings 30 Years of Experience in Finance, Strategy and Operations WALTHAM, Mass., April 28, 2025 (GLOBE ...